Plasma QconCATs reveal a gender-specific proteomic signature in apheresis platelet plasma supernatants

Journal of Proteomics

Volumn 120, Issue , 2015, Pages 1-6

  Dzieciatkowska, Monika ^a   D'Alessandro, Angelo ^a   Hill, Ryan C ^a   Hansen, Kirk C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Donor variability; Storage; Targeted proteomics; Transfusion medicine

Indexed keywords

ALCOHOL DEHYDROGENASE; THROMBOCYTE CONCENTRATE; BIOLOGICAL MARKER; PLASMA PROTEIN; PROTEOME;

AFFINITY CHROMATOGRAPHY; ARTICLE; CENTRIFUGATION; COMPLEMENT SYSTEM; DRUG SAFETY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEOMICS; SEX DIFFERENCE; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS; BLOOD; CHEMISTRY; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SCREENING; METABOLISM; PROCEDURES; SEXUAL DEVELOPMENT; THROMBOCYTE;

BIOMARKERS; BLOOD PLATELETS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MASS SPECTROMETRY; PLATELETPHERESIS; PROTEOME; SEX CHARACTERISTICS;

EID: 84924577388     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.02.010     Document Type: Article

References (23)

1. Burkhart J.M., Gambaryan S., Watson S.P., Jurk K., Walter U., Sickmann A., et al. What can proteomics tell us about platelets?. Circ Res 2014, 114:1204-1219. 10.1161/CIRCRESAHA.114.301598.
2. Chen Z., Schubert P., Culibrk B., Devine D.V. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Transfusion (Paris) 2014, 10.1111/trf.12905.
3. Prudent M., D'Alessandro A., Cazenave J.-P., Devine D.V., Gachet C., Greinacher A., et al. Proteome changes in platelets after pathogen inactivation-an interlaboratory consensus. Transfus Med Rev 2014, 28:72-83. 10.1016/j.tmrv.2014.02.002.
4. Thiele T., Iuga C., Janetzky S., Schwertz H., Gesell Salazar M., Fürll B., et al. Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ[U+2083] and focal adhesion signaling pathways. J Proteomics 2012, 76:297-315. [Spec]. 10.1016/j.jprot.2012.04.057.
5. Klockenbusch C., Walsh G.M., Brown L.M., Hoffman M.D., Ignatchenko V., Kislinger T., et al. Global proteome analysis identifies active immunoproteasome subunits in human platelets. Mol Cell Proteomics MCP 2014, 10.1074/mcp.M113.031757.
6. Van Holten T.C., Bleijerveld O.B., Wijten P., de Groot P.G., Heck A.J.R., Barendrecht A.D., et al. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. Cardiovasc Res 2014, 103:140-146. 10.1093/cvr/cvu113.
7. Gajic O., Yilmaz M., Iscimen R., Kor D.J., Winters J.L., Moore S.B., et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med 2007, 35:1645-1648. 10.1097/01.CCM.0000269036.16398.0D.
8. Dzieciatkowska M., D'Alessandro A., Burke T.A., Kelher M.R., Moore E.E., Banerjee A., et al. Proteomics of apheresis platelet supernatants during routine storage: gender-related differences. J Proteomics 2014, 112C:190-209. 10.1016/j.jprot.2014.08.016.
9. Schubert P., Culibrk B., Karwal S., Slichter S.J., Devine D.V. Optimization of platelet concentrate quality: application of proteomic technologies to donor management. J Proteomics 2012, 76:329-336. [Spec]. 10.1016/j.jprot.2012.06.023.
10. Glenister K.M., Payne K.A., Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion (Paris) 2008, 48:99-107. 10.1111/j.1537-2995.2007.01487.x.
11. Pratt J.M., Simpson D.M., Doherty M.K., Rivers J., Gaskell S.J., Beynon R.J. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc 2006, 1:1029-1043. 10.1038/nprot.2006.129.
12. Achour B., Russell M.R., Barber J., Rostami-Hodjegan A. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 2014, 42:500-510. 10.1124/dmd.113.055632.
13. Russell M.R., Achour B., Mckenzie E.A., Lopez R., Harwood M.D., Rostami-Hodjegan A., et al. Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters. J Proteome Res 2013, 12:5934-5942. 10.1021/pr400279u.
14. Silliman C.C., Dzieciatkowska M., Moore E.E., Kelher M.R., Banerjee A., Liang X., et al. Proteomic analyses of human plasma: Venus versus Mars. Transfusion (Paris) 2012, 52:417-424. 10.1111/j.1537-2995.2011.03316.x.
15. Deutsch E.W., Lam H., Aebersold R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep 2008, 9:429-434. 10.1038/embor.2008.56.
16. Picotti P., Lam H., Campbell D., Deutsch E., Mirzaei H., Ranish J., et al. A database of validated assays for the targeted mass spectrometric analysis of the S. cerevisiae proteome. Nat Methods 2008, 5:913-914. 10.1038/nmeth1108-913.
17. Craig R., Cortens J.P., Beavis R.C. Open source system for analyzing, validating, and storing protein identification data. J Proteome Res 2004, 3:1234-1242. 10.1021/pr049882h.
18. Brownridge P., Holman S.W., Gaskell S.J., Grant C.M., Harman V.M., Hubbard S.J., et al. Global absolute quantification of a proteome: challenges in the deployment of a QconCAT strategy. Proteomics 2011, 11:2957-2970. 10.1002/pmic.201100039.
19. Matic I., Jaffray E.G., Oxenham S.K., Groves M.J., Barratt C.L.R., Tauro S., et al. Absolute SILAC-compatible expression strain allows Sumo-2 copy number determination in clinical samples. J Proteome Res 2011, 10:4869-4875. 10.1021/pr2004715.
20. Egidi M.G., Rinalducci S., Marrocco C., Vaglio S., Zolla L. Proteomic analysis of plasma derived from platelet buffy coats during storage at room temperature. an application of ProteoMiner™ technology. Platelets 2011, 22:252-269. 10.3109/09537104.2010.550348.
21. Smalley D.M., Root K.E., Cho H., Ross M.M., Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007, 97:67-80.
22. Thon J.N., Schubert P., Duguay M., Serrano K., Lin S., Kast J., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion (Paris) 2008, 48:425-435. 10.1111/j.1537-2995.2007.01546.x.
23. Frese C.K., Altelaar A.F.M., Hennrich M.L., Nolting D., Zeller M., Griep-Raming J., et al. Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. J Proteome Res 2011, 10:2377-2388. 10.1021/pr1011729.